COPD
Conditions
Interventions
Hormone treatment group:Treatment with glucocorticoid during hospitalization
Control group:Not treated with glucocorticoid during hospitalization
Sponsors
The First People's Hospital of Shuangliu District, Chengdu
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. All patients were diagnosed as AECOPD according to the diagnostic criteria of global initiative on chronic obstructive pulmonary disease (gold) revised in 2018. 2. Patients aged between 18 and 95 years (including 18 and 95 years old) had stable pulmonary function examination report within 6 months before admission, and had good compliance. They could cooperate with the completion of chest HRCT, blood routine, PCT, blood gas analysis, sputum culture examination, and could follow the doctor's advice for treatment and medication. 3. Patients who use ICS / Laba or ICS / Laba + lam in stable period.
Exclusion criteria
Exclusion criteria: 1. Patients with incomplete clinical data, including patients without stable pulmonary function examination report within 6 months before admission, and patients without chest HRCT, blood routine, blood gas analysis, PCT and sputum culture examination during hospitalization. 2. Patients with other lung diseases, such as bronchial asthma, lung cancer, tuberculosis and pulmonary interstitial diseases. 3. Patients with serious heart, liver, kidney, digestive system, hematopoietic system, nervous system and mental system diseases. 4. Patients with consumptive diseases such as malignant tumor and hyperthyroidism.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| rate of severe acute COPD attacks per year; | — |
Countries
China
Contacts
Public ContactHuawei Li
The First People's Hospital of Shuangliu District, Chengdu
Outcome results
None listed